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aTATE-OF-THE-ART PAPER491HF in Women: A Need for Prospective Dataileen M. Hsich, Ileana L. Piña
his piece by Hsich and Piña reviews sex differences in the diagnosis and treatment of heart
ailure (HF) and offers practical suggestions to guide therapy when treating females with HF.
early 50% of those affected by HF are women. Women are less likely to have coronary
rtery disease and more likely to have hypertension and valvular disease. Women often
resent at an older age with better systolic function and have better survival. Despite these
nown sex differences, medical management recommendations are the same for women and
en since prospective sex-specific clinical trials have not been performed. However, this
eview suggests that women may respond differently to some therapies and that prospective
ex-specific data is needed.VIEWPOINT EALTH REFORM499The Role of the ACC and its Members in Promoting Health System Reformames T. Dove, W. Douglas Weaver, Jack Lewin
n this Viewpoint article, Drs. Dove, Weaver, and Lewin discuss the growing momentum for
ealth system reform and the role of the American College of Cardiology (ACC) in this
rocess. Designing a health care delivery system that delivers quality, patient-centered care
equires the involvement of both patients and medical professionals. The ACC is encouraging
ealth care providers to transform health care from the inside out. The ACC is also
dvocating for a system that encompasses these 6 principals necessary for reform: universal
overage, coverage through an expansion of public and private (pluralistic) programs, a focus
n patient value, emphasis on professionalism, coordination across sources and sites of care,
nd payment reforms that reward quality and ensure value.(continued on page A-14)
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fEWS FROM THE NHLBI502NHLBI Develops Website to Explain Pediatric Research to Children and Parentsictoria L. Pemberton, Jonathan R. Kaltman, Gail D. Pearson
n the fall of 2008, the National Heart, Lung, and Blood Institute (NHLBI) launched
hildren and Clinical Studies, a multimedia website to educate the public and researchers
bout children’s participation in clinical research. The “no more hand-me-downs” theme
mphasizes the importance of research focused on pediatric conditions. Both children and
arents will find information about participating in a research trial, which should facilitate the
rocess of informed consent and hopefully improve the likelihood that children will
articipate.CLINICAL RESEARCH LINICAL TRIAL505Spironolactone Reduces LV Hypertrophy in Patients With CKDicola C. Edwards, Richard P. Steeds, Paul M. Stewart, Charles J. Ferro, Jonathan N. Townend
ctivation of the renin-angiotensin-aldosterone system in patients with chronic kidney disease
CKD) is believed to cause left ventricular (LV) hypertrophy and arterial stiffness. Edwards
nd colleagues randomized subjects with CKD (glomerular filtration rate 30 to 69 ml/min/
.73 m2) who were already taking an angiotensin-converting enzyme inhibitor or an
ngiotensin receptor blocker to 25 mg/day of spironolactone or placebo. LV mass and arterial
tiffness were measured before and after 40 weeks of treatment. Compared with placebo,
pironolactone resulted in significant reductions in LV mass (14 g vs. 3 g), pulse wave
elocity, augmentation index, and improved aortic distensibility. The utility of spironolactone
or reducing adverse cardiovascular events in patients with CKD merits further study.ditorial Comment: William C. Little, Paul M. Kirkman, p. 513ORONARY ARTERY DISEASE515Wide Variations in Frequency of Referrals for Cardiac Rehabilitationodd M. Brown, Adrian F. Hernandez, Vera Bittner, Christopher P. Cannon, Gray Ellrodt, Li Liang,
ric D. Peterson, Ileana L. Piña, Monika M. Safford, Gregg C. Fonarow, on behalf of the American Heart
ssociation Get With The Guidelines Investigators
ardiac rehabilitation reduces morbidity and mortality and is a Class I indication following
yocardial infarction (MI) or revascularization. However, it appears to be underutilized, with
nly 19% of Medicare patients with appropriate indications enrolled. Brown and colleagues
nalyzed over 70,000 patients discharged alive following an MI, percutaneous coronary
ntervention, or coronary artery bypass graft surgery from 156 hospitals. Only 56% were
eferred to cardiac rehabilitation at discharge. The referral rate by hospital ranged from 0% to
00%: only one-third of hospitals referred 60% of eligible patients. Despite strong evidence
or benefit, only one-half of eligible patients are referred for cardiac rehabilitation.(continued on page A-15)
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iEART RHYTHM DISORDERS522Ablation May Reduce Frequency of Idiopathic VFébastien Knecht, Frédéric Sacher, Matthew Wright, Mélèze Hocini, Akihiko Nogami, Thomas Arentz,
ertrand Petit, Robert Franck, Christian De Chillou, Dominique Lamaison, Jéronimo Farré,
homas Lavergne, Thierry Verbeet, Isabelle Nault, Seiichiro Matsuo, Lionel Leroux, Rukshen Weerasooriya,
runo Cauchemez, Nicolas Lellouche, Nicolas Derval, Sanjiv M. Narayan, Pierre Jaïs, Jacques Clementy,
ichel Haïssaguerre
his multicenter study sought to evaluate the long-term efficacy of ablation for idiopathic
entricular fibrillation (VF). Thirty-eight consecutive patients underwent ablation of primary
diopathic VF that was triggered by a short coupled ventricular premature beat (VPB). Most
ubjects had experienced 2 or more VF episodes in the preceding year. Catheter ablation was
uided by activation mapping of VPBs. During a median post-procedural follow-up of 63
onths, only 18% of patients experienced VF recurrence; 5 of the 7 who had recurrent VF
nderwent a second ablation with no subsequent VF episodes. Ablation for idiopathic VF
ay reduce the frequency of VF episodes for patients with idiopathic VF.ditorial Comment: Bruce D. Lindsay, p. 529EART RHYTHM DISORDERS
531eople With Anxiety and Emotional Distress
at Increased Risk for Ventricular Arrhythmiasrista C. van den Broek, Ivan Nyklı´cˇek, Pepijn H. van der Voort, Marco Alings, Albert Meijer, Johan Denollet
his prospective study by van den Broek and colleagues examined the interaction between
ype D personality and the risk for ventricular arrhythmias. Type D patients tend to
xperience increased negative emotions (e.g., worry, having a gloomy view of life) paired with
motional nonexpression. Almost 400 patients were assessed for anxiety, depression, and Type
personality prior to implantation of an implantable cardioverter-defibrillator. Neither
epression nor anxiety predicted subsequent arrhythmias. However, anxious patients with a
ype D personality had a significantly increased rate of ventricular arrhythmias (adjusted
azard ratio: 1.7). Personality traits may modify the effect of anxiety in pre-disposing to
ncreased risk of ventricular arrhythmias.(continued on page A-16)
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EARDIAC IMAGING538Perfusion Imaging May Be Unnecessary in Those Who Achieve >10 METs of Exerciseamieson M. Bourque, Benjamin H. Holland, Denny D. Watson, George A. Beller
ourque and colleagues sought to identify the prevalence of significant ischemia (defined as
10% of the left ventricle [LV]) on exercise single-photon emission computed tomography
maging in patients able to achieve 10 metabolic equivalents (METs) of exercise and 85%
f their maximum age-predicted heart rate. Of the approximately 500 subjects who achieved
10 METs, only 0.4% had significant ischemia; no patient who achieved 10 METs
ithout exercise ST-segment depression had 10% LV ischemia, and only 0.7% had 5% to
% LV ischemia. The authors suggest that patients who achieve 10 METs without ST-
egment depression do not need to be injected with nuclear tracer, potentially resulting in
ignificant cost savings.ditorial Comment: Frans J. Th. Wackers, p. 546ARDIAC IMAGING549MRI May Be Safe in Patients With ICDslaas P. Naehle, Katharina Strach, Daniel Thomas, Carsten Meyer, Markus Linhart, Sascha Bitaraf,
arold Litt, Jörg Otto Schwab, Hans Schild, Torsten Sommer
erforming a magnetic resonance imaging (MRI) scan on a patient with an implantable
ardioverter-defibrillator (ICD) may be more dangerous than on a patient with a traditional
acemaker. Naehle and colleagues report on their experience performing MRI on 18 patients
ith ICDs. Nonpacemaker-dependent ICD patients had their ICDs reprogrammed pre-MRI
o minimize pacing, and arrhythmia detection was programmed on, but therapy delivery off.
ll examinations were completed safely with no patient symptoms. No significant changes of
apture thresholds or lead impedance were observed. In 2 magnetic resonance examinations,
versensing of radiofrequency noise as ventricular fibrillation occurred. In conclusion, MRI of
onpacemaker-dependent ICD patients can be performed under controlled conditions by
aking both MRI- and pacemaker-related precautions.ditorial Comment: Ariel Roguin, p. 556
